Osmetech to Use TriLink Reagents | GenomeWeb

NEW YORK (GenomeWeb News) — TriLink BioTechnologies will provide Osmetech Molecular Diagnostics with reagents for its new cystic fibrosis and warfarin sensitivity tests, TriLink said today.

TriLink said it will provide Osmetech with custom oligonucleotides required for its eSensor Cystic Fibrosis Carrier Detection System and its eSensor XT-8 System for warfarin sensitivity.

San Diego-based TriLink makes custom oligonucleotides, nucleoside triphosphates, and PCR products for the diagnostic and OEM markets.

Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.